Submit Manuscript  

Article Details


Cardioprotective Utility of Urocortin in Myocardial Ischemia- Reperfusion Injury: Where do We Stand?

[ Vol. 11 , Issue. 1 ]

Author(s):

Craig Basman, Pratik Agrawal, Richard Knight, Louis Saravolatz, Chad McRee, Carol Chen-Scarabelli, Jagat Narula and Tiziano Scarabelli*   Pages 32 - 38 ( 7 )

Abstract:


Background: There has been a constant pursuit for development of newer therapies which can contribute to the relatively nascent field of cardioprotection in the setting of myocardial ischemiareperfusion injury. One novel cardioprotective agent among others, that has shown promising results in the limited number of research studies undertaken till now, is Urocortin. Urocortins are peptides belonging to the Corticotropin-Releasing Hormone family.

Results: Acting through a variety of downstream mechanisms, urocortin has been shown to alter cellular metabolism and modulate the mechanism of cell death occurring as a result of ischemia-reperfusion injury. New evidence continues to accumulate in support of urocortin’s beneficial role in cytoprotection.

Conclusion: We present here an updated review largely focused on the various mechanisms through which urocortin alters cellular metabolism, and discuss the clinical potential of urocortin’s cardioprotective ability in myocardial ischemia-reperfusion injury.

Keywords:

Urocortin, ischemia-reperfusion, cytoprotection, corticotropins, cell death, cellular metabolism, myocardial.

Affiliation:

Lenox Hill Hospital, North Shore LIJ Health System, New York, NY, St. John Hospital and Medical Center, Wayne State University Medical School, Detroit, MI, St. John Hospital and Medical Center, Wayne State University Medical School, Detroit, MI, St. John Hospital and Medical Center, Wayne State University Medical School, Detroit, MI, Virginia Commonwealth University Medical Center Department of Cardiology, Alabama, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, Alabama, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, NY, Virginia Commonwealth University Medical Center Department of Cardiology, Alabama

Graphical Abstract:



Read Full-Text article